The Amyotrophic Lateral Sclerosis M114T PFN1 Mutation Deregulates Alternative Autophagy Pathways and Mitochondrial...

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Mutations in profilin 1 (PFN1) are linked to rare familial Amyotrophic Lateral Sclerosis (ALS).
• The precise pathogenic mechanisms of PFN1 mutations in ALS remain unclear.
• PFN1's role in cellular pathways suggests potential involvement in ALS pathology.

Purpose of the Study:

• To investigate the role of PFN1 in regulating autophagy pathways.
• To determine if PFN1 mutations disrupt autophagic function in ALS.
• To compare the pathogenic effects of different PFN1 mutations (M114T and E117G).

Main Methods:

• Utilized patient-derived cells (lymphoblasts) and post-mortem tissues with PFN1 mutations.
• Developed experimental models including cell lines and novel PFN1 transgenic mice.
• Assessed autophagic pathway markers in cells and tissues expressing wild-type or mutant PFN1.

Main Results:

• The M114T PFN1 mutant protein exhibited instability and dysregulated the RAB9-mediated alternative autophagy pathway.
• Mitochondrial abnormalities were observed in motor neurons expressing M114T mutant PFN1.
• The E117G mutation showed less deleterious effects compared to M114T in cellular and animal models.

Conclusions:

• The M114T PFN1 mutation is more detrimental than the E117G variant in ALS models.
• PFN1 mutations disrupt the RAB9-dependent autophagy pathway crucial for clearing damaged mitochondria.
• This study highlights the RAB9-mediated autophagic pathway as a potential player in ALS pathogenesis.